MedTrace Logo

In Vitro Maturation (IVM) of Human Oocytes

NCT01843569 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2020-11-16

No results posted yet for this study

Summary

We hypothesize that the combination of natural cycle IVF or low dose gonadotropin injection combined with In Vitro Maturation (IVM) (Natural IVF/IVM) is a viable option for a selected population of infertility patients who cannot tolerate exogenous gonadotropins or are at risk of ovarian hyperstimulation syndrome.

Conditions

  • Polycystic Ovarian Syndrome (PCOS)
  • Patients Sensitive to Exogenous Gonadotropins
  • Ovarian Hyper Stimulation Syndrome (OHSS)

Interventions

BIOLOGICAL

In Vitro maturation

Sponsors & Collaborators

  • Northwell Health

    lead OTHER

Principal Investigators

  • Avner Hershlag, MD · NSLIJ

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
25 Years
Max Age
42 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-01-31
Primary Completion
2019-12-31
Completion
2020-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01843569 on ClinicalTrials.gov